The Spoonbill Foundation is a US-based nonprofit organization dedicated to finding treatments for PKAN and other NBIA disorders. With a strong focus on scientific research and community involvement, they aim to expedite the development and delivery of therapeutics while maintaining low costs. Their work is a collaboration with their sister organization in the Netherlands, Stichting Lepelaar.
2017
81-5080532
$784.6 thousand

The US/Canada CoA-Z clinical trial has started enrolling participants.

General updates provided regarding the CoA-Z phase II clinical trial.

The Spoonbill Foundation aims to raise nearly $2M to bring CoA-Z to clinical testing.
Overall Score
48
42
/100
Program Expense Ratio
100.00%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
2.828
16
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 17.91K | 98.62% |
| Program Services | 0 | 0.00% |
| Investment Income | 251 | 1.38% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 18.17K | 100.00% |
Med Research
NEC Medical Research SupportMed Research
NEC Medical Research SupportMed Research
NEC Medical Research SupportMed Research
NEC Medical Research SupportMed Research
NEC Medical Research Support